The studio
Human- and data‑centric AI design — a career-long practice, not a recent pivot.
Grace S. Lee is Founder & CEO of Health Enovation, Inc. For 30+ years in clinical research and drug development she has designed human‑ and data‑centric systems, and more recently AI systems, that put models and data next to the people accountable for decisions — safety physicians, regulators, clinicians, and national health leaders — rather than as stand-alone tools. Today, through Health Enovation, she advises pharma, health systems, and governments, including integrated Safety Intelligence Systems for Sanofi and Pfizer and real‑world data strategy for Pfizer and AbbVie. While at PA Consulting she built CLASS (Clinical and Safety Signal Intelligence System) on Google technology in 2013 — demonstrated on a CIO roadshow including the Gartner CIO conference and presented to the EMA, MHRA, NIHR and top 15 global pharma and biotech companies. Case narrative automation began while at a pharma company (2006–07), then at Covance (2008–10) for Bayer and more than 50 other pharma and biotech clients, including a 2008 Bayer language model that regulators accepted in NDA approvals. In 1999–2001 she led the launch of Lipitor, Viagra, Neurontin and Lexapro for Warner-Lambert, Pfizer and Forest via human‑ and data‑centric integration; her practice is rooted in academic research — cell-cycle and Alzheimer’s work — and earliest published presentations on cellular communication (National Academy of Sciences, 1992; AAAS Annual Meeting, San Francisco, 1993).
